MedTrace Logo

Eye Movement Desensitization and Reprocessing (EMDR) as a Treatment of Substance Use Disorders

NCT03114423 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-08-05

No results posted yet for this study

Summary

The purpose of this clinical study is to examine the established, therapeutic EMDR intervention for patients with substance use disorders (SUD). The EMDR method is an integrative and structured therapeutic method which assumes that memories which have been dysfunctionally stored can lead to harmful behavior. The EMDR protocol used for this clinical trials has been specifically developed for patients with SUD - the results should be compared with traditional therapy. For the assessment of the EMDR treatment some questionnaires are given at several times.

Conditions

Interventions

OTHER

EMDR-Therapy

The EMDR-protocol from Hase (2008) was used

OTHER

Sham Intervention

For the training the COGPACK-program from Marker (2008) was used

Sponsors & Collaborators

  • Medical University of Graz

    collaborator OTHER

  • Center of Integrative Addiction Research, Austria

    lead OTHER

Principal Investigators

  • Human-Friedrich Unterrainer, PD DDr. · Center of Integrative Addiction Research, Austria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-07
Primary Completion
2020-09-30
Completion
2021-07-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03114423 on ClinicalTrials.gov